BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17139367)

  • 1. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
    Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
    Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
    Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
    Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    J Vasc Surg; 2005 Aug; 42(2):252-8. PubMed ID: 16102623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
    Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
    Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.
    Angiolillo DJ; Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Sumner S; Desai B; Charlton RK; Box LC; Zenni M; Guzman LA; Bass TA
    Thromb Haemost; 2011 Aug; 106(2):253-62. PubMed ID: 21614414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
    Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
    Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and clopidogrel.
    Ahn JC; Song WH; Kwon JA; Park CG; Seo HS; Oh DJ; Rho YM
    Korean J Intern Med; 2004 Dec; 19(4):230-6. PubMed ID: 15683111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
    Xiao Z; Théroux P
    J Am Coll Cardiol; 2004 Jun; 43(11):1982-8. PubMed ID: 15172401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol could ameliorate platelet responsiveness to clopidogrel in patients undergoing primary percutaneous coronary intervention.
    Kim JY; Lee K; Shin M; Ahn M; Choe H; Yoo BS; Yoon J; Choe KH; Lee SH
    Circ J; 2007 Dec; 71(12):1867-72. PubMed ID: 18037738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

  • 18. Clopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery disease.
    Stellbaum C; Willich T; Boltzen U; Ayral Y; Szotowski B; Piorkowski M; Schultheiss HP; Rauch U
    Eur J Haematol; 2007 Apr; 78(4):347-52. PubMed ID: 17331131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination.
    Comerota AJ
    Atheroscler Suppl; 2005 Dec; 6(4):13-9. PubMed ID: 16275168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
    Wilson AM; Brittenden J; Bachoo P; Ford I; Nixon GF
    J Vasc Surg; 2009 Oct; 50(4):861-9. PubMed ID: 19786240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.